Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia.
Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
Clin Chem Lab Med. 2018 Feb 23;56(3):454-462. doi: 10.1515/cclm-2017-0402.
The need to satisfy high-throughput demands for laboratory tests continues to be a challenge. Therefore, we aimed to automate postanalytical phase in hematology and coagulation laboratory by autovalidation of complete blood count (CBC) and routine coagulation test results (prothrombin time [PT], international normalized ratio [PT-INR], activated partial thromboplastin time [APTT], fibrinogen, antithrombin activity [AT] and thrombin time [TT]). Work efficacy and turnaround time (TAT) before and after implementation of automated solutions will be compared.
Ordering panels tailored to specific patient populations were implemented. Rerun and reflex testing rules were set in the respective analyzers' software (Coulter DxH Connectivity 1601, Beckman Coulter, FL, USA; AutoAssistant, Siemens Healthcare Diagnostics, Germany), and sample status information was transferred into the laboratory information system. To evaluate if the automation improved TAT and efficacy, data from manually verified results in September and October of 2015 were compared with the corresponding period in 2016 when autovalidation was implemented.
Autovalidation rates of 63% for CBC and 65% for routine coagulation test results were achieved. At the TAT of 120 min, the percentage of reported results increased substantially for all analyzed tests, being above 90% for CBC, PT, PT-INR and fibrinogen and 89% for APTT. This output was achieved with three laboratory technicians less compared with the period when the postanalytical phase was not automated.
Automation allowed optimized laboratory workflow for specific patient populations, thereby ensuring standardized results reporting. Autovalidation of test results proved to be an efficient tool for improvement of laboratory work efficacy and TAT.
满足实验室检测高通量需求的需求仍然是一个挑战。因此,我们旨在通过对全血细胞计数(CBC)和常规凝血检测结果(凝血酶原时间[PT]、国际标准化比值[PT-INR]、活化部分凝血活酶时间[APTT]、纤维蛋白原、抗凝血酶活性[AT]和凝血酶时间[TT])进行自动验证,实现血液学和凝血实验室的分析后阶段自动化。将比较实施自动化解决方案前后的工作效率和周转时间(TAT)。
实施了针对特定患者人群的定制化检测面板。在各自的分析仪软件(Coulter DxH Connectivity 1601、Beckman Coulter、FL、USA;AutoAssistant、Siemens Healthcare Diagnostics、德国)中设置了重测和反射测试规则,并将样本状态信息传输到实验室信息系统中。为了评估自动化是否提高了 TAT 和效率,将 2015 年 9 月和 10 月手动验证结果的数据与 2016 年实施自动验证时的相应时间段进行了比较。
CBC 的自动验证率达到了 63%,常规凝血检测结果的自动验证率达到了 65%。在 120 分钟的 TAT 下,所有分析测试的报告结果百分比都大幅增加,CBC、PT、PT-INR 和纤维蛋白原的报告结果百分比均超过 90%,APTT 的报告结果百分比为 89%。与未实现分析后阶段自动化的时期相比,该输出结果使用的实验室技术人员减少了三人。
自动化允许针对特定患者人群优化实验室工作流程,从而确保标准化的结果报告。检测结果的自动验证已被证明是提高实验室工作效率和 TAT 的有效工具。